Jill M. Siegfried

University of Minnesota — United States

Medicine · Health Sciences

65h-index12.4kcitations409works10.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Treatments and Mutations(145), Cytokine Signaling Pathways and Interactions(49), RNA modifications and cancer(40), Peptidase Inhibition and Analysis(38), Lung Cancer Research Studies(33)

Publications408 total

The American Cancer Society National Lung Cancer Roundtable strategic plan: Lung cancer in women
Cancer·2024· 10 citedOpen Access
Early Natural Menopause Is Associated With Poor Lung Health and Increased Mortality Among Female Smokers
Obstetrical & Gynecological Survey·2023
Data from Early Changes in Pulmonary Gene Expression following Tobacco Exposure Shed Light on the Role of Estrogen Metabolism in Lung Carcinogenesis
2023Open Access
Figure S2 from Prevention of Tobacco Carcinogen-Induced Lung Tumor Development by a Novel STAT3 Decoy Inhibitor
2023Open Access
Data from Prevention of Tobacco Carcinogen-Induced Lung Tumor Development by a Novel STAT3 Decoy Inhibitor
2023Open Access
Supplementary Figure 1B from Kinin B2 Receptor Mediates Induction of Cyclooxygenase-2 and Is Overexpressed in Head and Neck Squamous Cell Carcinomas
2023Open Access
Supplemental Figure 3 from STAT3 Cyclic Decoy Demonstrates Robust Antitumor Effects in Non–Small Cell Lung Cancer
2023Open Access
Figure S1 from Prevention of Tobacco Carcinogen-Induced Lung Tumor Development by a Novel STAT3 Decoy Inhibitor
2023Open Access
Related Article from Early Changes in Pulmonary Gene Expression following Tobacco Exposure Shed Light on the Role of Estrogen Metabolism in Lung Carcinogenesis
2023Open Access
Data from Kinin B2 Receptor Mediates Induction of Cyclooxygenase-2 and Is Overexpressed in Head and Neck Squamous Cell Carcinomas
2023Open Access
Supplemental Figure 4 from STAT3 Cyclic Decoy Demonstrates Robust Antitumor Effects in Non–Small Cell Lung Cancer
2023Open Access
Supplemental Figure 1 from STAT3 Cyclic Decoy Demonstrates Robust Antitumor Effects in Non–Small Cell Lung Cancer
2023Open Access
Data from Myeloid STAT3 Promotes Lung Tumorigenesis by Transforming Tumor Immunosurveillance into Tumor-Promoting Inflammation
2023Open Access
Supplementary Data legends from Prevention of Tobacco Carcinogen-Induced Lung Tumor Development by a Novel STAT3 Decoy Inhibitor
2023Open Access
Supplemental Figure 1 from STAT3 Cyclic Decoy Demonstrates Robust Antitumor Effects in Non–Small Cell Lung Cancer
2023Open Access
Related Article from Early Changes in Pulmonary Gene Expression following Tobacco Exposure Shed Light on the Role of Estrogen Metabolism in Lung Carcinogenesis
2023Open Access
Figure S5 from Prevention of Tobacco Carcinogen-Induced Lung Tumor Development by a Novel STAT3 Decoy Inhibitor
2023Open Access
Data from STAT3 Cyclic Decoy Demonstrates Robust Antitumor Effects in Non–Small Cell Lung Cancer
2023Open Access
Data from STAT3 Cyclic Decoy Demonstrates Robust Antitumor Effects in Non–Small Cell Lung Cancer
2023Open Access
Supplemental Figure 3 from STAT3 Cyclic Decoy Demonstrates Robust Antitumor Effects in Non–Small Cell Lung Cancer
2023Open Access
page 1 of 21Next →

Frequent Co-authors

Laura P. Stabile(13), Jennifer R. Grandis(11), James D. Luketich(10), Rodney J. Landreneau(10), Christopher T. Gubish(9), David O. Wilson(6), Joel L. Weissfeld(6), Sufi M. Thomas(6), William L. Bigbee(5), William E. Gooding(4), Matthew J. Schuchert(4), Carl R. Fuhrman(3), Toni M. Hopkins(3), Ann Marie Egloff(3), Mary E. Rothstein(3), Pamela A. Hershberger(3), Stephanie R. Land(3), Phouthone Keohavong(3), Robert J. Weyant(3), Joseph R. Testa(3)